*****ELITE PHARMACUTICAL(ELTP)***** --8 FDA approved

New Post Public Reply Private Reply Replies (0) Message Board
NASDAQ2020

*****ELITE PHARMACUTICAL(ELTP)*****

--8 FDA approved drugs: hydromorphone, phentermine 37.5 mg, lodrane D, methadone, phendimetazine, phentermine 15mg, phentermine 30mg, naltrexone 50mg
--4 quarters of increasing revenues
--Lodrane 24 and 24D returning after being pulled by FDA with 500 other cold/flu products
--Lodrane D  OTC gaining market share
--cash flow positive(CFP) probably this quarter
--CEO Jerry Trepple  loaned the co. 1 million dollars unsecured (non-dilutive)
--interest paid in full on loans
--ELI-216 Controlled released (CR) Abuse Resistant(ART) opiods are a priority, further along than people think per the CEO
--1st patent for ELI-216 8/182,836 abuse resistant oral formulations and method of use thereof (approved May 22, 2012)
--2nd patent for ELI-216 8/425.933 formerly 12/640,344(approval due week of April, 21 2013) combined with first patent, gives Elite a hammerlock on superior 2 bead ART(abuse resistant tech)
--Patent pending 13/379,486 microtablet 0.25-1.0mm smallest in the industry for use with ALL medicines
--Patent pending 13/379,481 microtablets for use with abuse resistant products
-- 2 BEAD abuse resistant technology is a superior ART, it is Modular meaning it can be easily used for ALL opiods not just oxy
--ELI-216 is a controlled release 24 hr abuse resistant oxy requiring Phase III clinical trials, after which it can be used for ALL opiods. Trials could start any time.
--partner for ELI-216 could be announced any day
--patent 12/075,816  Sequestering polymer acrylic co-polymer composition: ON HOLD while Elite and lawyers Washburn&Woodcock strategize to add more claims
--Novel net worth growing, 31 FDA approved drugs including generic morning after pill
--Elite owns 10% of Novel Labs, Novel has approached Elite for monetization
--estimates for 10% value of Novel range from 10 million to 50 million
--Elites 3.5 million debt will be eliminated with sale of Novel
--current launched drugs continue to gain market share
--phentermine 15/30mg launched (April 11, 2013) will compete with Qsymia(phentermine and topiramate)
--BE and PK studies progressing, some maybe completed or near completion
--New Jersey(NJEDA) tax credits approaching 1 million dollars/yr
--Impressive billion dollar pipeline
--multiple partners supporting Elite: Watson/Actavis, Mikah, Epic, TAGI, The Pharm Network, ECR, Precision Dose, Celgene Corp and the undisclosed Hong Kong Pharma
--contracting deals with other Pharmas
--NEW Packaging line operational, making and saving the co.  money, adding to the bottom line
--TWO 15,000 sq/ft FDA-DEA-GMPc registered manufacturing labs for research, development and manufacturing from concept to commercialization
-- 26 employees up from 16, 2 years ago
-- 4-5 drugs in *Scale Up*
--Hong Kong NDA progressing
--MIK-001 probably an improved Embeda
--HITK's 100 million dollar branded intermediate
--first of 8 Epic drugs due out anytime
--505(b)(2)opportunities's for ART generics and NDA's where Bio-equivalency studies alone are enough (no phase III trials)
--STOPP ACT - a bill before Congress now, introduced by US Rep's Rahall, Rogers and Keating. The Gov. will prohibit any old-formula opiod from enterng the market if the FDA has an equivalent ART opiod approved
--Naltrexone FDA approved, launch pending (May-June 2013)
--undisclosed ANDA's could come out any day 
--CEO's goal is to comercialize a COMPLETE LINE of abuse resistant opiods
--Relisting on NASDAQ 2-4 years

ELTP

Elite Pharmaceuticals Inc (ELTP) Stock Research Links

ELTP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tessera Delisting Leaves HLSQ in a Tougher Market Ahead

Updated Category News Views 116

November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...

Continue Reading
HVAC’s $383.6 Billion Shift Is About More Than Units

Updated Category News Views 163

Server racks are turning cooling gear into a front-row industrial story, and that deserves more attention than the usual sleepy talk about replacement air conditioners. Frost & Sullivan projects the global HVAC equipment market will reach $383.6 billion by 2031, growing at a 7.0% compound annual rate from 2025. That is a sizable market, sure, but the more interesting...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 148

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
Sprocket’s GigaOm Leap Puts PTaaS Claims Under Scrutiny

Updated Category News Views 91

Security vendors love a shiny quadrant, but this one deserves more than the usual polite golf clap. Sprocket Security moved from Challenger and Outperformer in GigaOm’s 2025 Penetration Testing as a Service assessment to a Leader in the version 5 report released in 2026. That is a meaningful jump in a category where buyers are tired of annual testing reports that go...

Continue Reading
Mason Adds Nonprofit Expertise to Institutional Bench

Updated Category News Views 110

Endowment committees rarely need more noise; they need somebody who has actually sat through the uncomfortable votes. Mason Investment Advisory Services has hired Rebecca “Becky” Farnsworth, CFA, as a senior investment consultant, and this looks like a practical addition rather than the usual chest-thumping personnel announcement. Her stated focus will be...

Continue Reading
Childcare Scale Makes Its Case, With Caveats Attached

Updated Category News Views 58

Childcare’s math is brutal before anybody starts arguing over ownership. Families need dependable hours, educators deserve better pay, and operators must keep buildings safe, staffed and open without pricing working parents clean out of the market. That is why this new Tyton Partners review of multi-site providers deserves a fair look, even if nobody should mistake a...

Continue Reading
Shenzhen’s 50-Year Message Carries Real Trade Weight

Updated Category News Views 68

A city once framed as a frontier fishing village is being presented as China’s sharpest recent economic before-and-after picture. At the welcome dinner for the 33rd APEC Economic Leaders’ Meeting in Shenzhen, President Xi Jinping gave guests a compact geographic guide to China’s past: Xi’an for thousands of years, Beijing for 500 years, Shanghai for 100 years, and...

Continue Reading
Digital Diabetes Care Has a Bigger Prize Than Devices

Updated Category News Views 144

A glucose sensor is becoming less a gadget than a running conversation between patient, clinician and software. That shift matters because diabetes management is leaving the occasional clinic visit and moving into daily life, where the useful product is not merely a reading but a pattern someone can act on. The sector deserves attention from investors, but it also...

Continue Reading
Saturn and Tileward Put GPU Memory Back to Work Now

Updated Category News Views 49

GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...

Continue Reading
Pennsylvania Housing Finds Its October Holding Pattern

Updated Category News Views 108

Pennsylvania's October housing numbers have the uneasy stillness of a pond before somebody throws a rock. The statewide median sales price sat at $315,000, exactly where it was in September, while sales barely cleared 10,400 and available listings kept inching higher. Nothing in that mix screams boom or bust. Frankly, that is the point: a market can look calm on the...

Continue Reading

Top 5 Most Recently Viewed Articles

AI Data Risks and the Urgent Need for Enhanced Security Measures

Updated Category News Views 233

AI Data Security Threats Revealed by Varonis In a recent study conducted by Varonis, a prominent data security firm, alarming findings have surfaced regarding the vulnerabilities in organizations’ data systems. The report indicates that an overwhelming 99% of businesses have sensitive data that is exposed to artificial intelligence (AI) tools. This raises significant...

Continue Reading
Volt Lithium's Groundbreaking Daily Output Achieved with New Tech

Updated Category News Views 170

Volt Lithium Achieves Remarkable Milestone Volt Lithium Corp. is excited to announce that it has completed a 24-hour continuous run of its Generation 5 Field Unit, achieving an impressive throughput of 11,573 barrels per day. This significant milestone not only exceeds the initial target of 10,000 barrels per day but also demonstrates the company’s rapid advancements in...

Continue Reading
Investors Urged to Act Before PepGen Legal Deadline Approaches

Updated Category News Views 169

Urgent Reminder for PepGen Investors As the deadline approaches, it is vital for affected investors to take immediate action regarding their stakes in PepGen Inc. The renowned law firm, Bragar Eagel & Squire, P.C., is advocating for those who have incurred losses related to their investments in PepGen (PEPG). If you have purchased or otherwise acquired securities in...

Continue Reading
Gaumont's Voting Rights and Share Capital Information Revealed

Updated Category News Views 166

Gaumont’s Recent Disclosure on Voting Rights and Share Capital Gaumont, a well-known name in the film industry, recently shared important details about its voting rights and share capital. This information is crucial for current and prospective investors, providing transparency and clarity regarding the company’s governance structure. Key Details as per Article L....

Continue Reading
EAM-Mosca to Showcase Innovative Packaging Solutions at Expo

Updated Category News Views 170

EAM-Mosca to Showcase Innovative Packaging Solutions at SuperCorr Expo EAM-Mosca is excited to announce its participation in the upcoming SuperCorr Expo, where it will present its latest state-of-the-art strapping and wrapping solutions at Booth #2031. Attendees will have the opportunity to see firsthand how these solutions can improve efficiency and provide enhanced...

Continue Reading